Predict your next investment

HEALTHCARE | Biotechnology
eribispharma.se

See what CB Insights has to offer

Investors Count

1

Eribis Pharmaceuticals Funding, Eribis Pharmaceuticals Valuation & Eribis Pharmaceuticals Revenue

1 Fundings

Eribis Pharmaceuticals's latest funding round was a Seed for on January 26, 2010.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/26/2010

Seed

$0.00B

((9.99x))

FY 1234

1

Date

1/26/2010

Round

Seed

Amount

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

Sources

1

Eribis Pharmaceuticals Investors

1 Investors

Eribis Pharmaceuticals has 1 investors. Karolinska Development invested in Eribis Pharmaceuticals's Seed funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/26/2010

1/26/2010

1
Seed

Asset/Investment Management

Sweden

First funding

1/26/2010

Last Funding

1/26/2010

Investor

Rounds

1
Seed

Board Seats

Type

Asset/Investment Management

Location

Sweden

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.